by According to a research report “Clinical Communication & Collaboration Market (By Component: Solution and Service; End Use: Hospitals and Clinics; Deployment: Hosted and On-premise) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2021 – 2030″ published by Precedence Research.
The clinical communication and collaboration market size is projected to hit from USD 4 billion in 2022 to USD 6 billion by 2030, growing at a CAGR of 4% every year.
The study provides an analysis of the period 2017-2030, wherein 2021 to 2030 is the forecast period and 2021 is considered as the base year.
The global clinical communication and collaboration market is primarily driven by the rising need for the effective communication systems in healthcare sector to eliminate the medical errors that occur due to lack of effective communication. The CC&C market is significantly driven by the availability of several features at a single platform. The CC&C systems integrates the medical alarming, text messaging, and video communication at a single platform that helps in effective communication among the hospital staffs. This one stop solution is expected to boost its adoption in clinics and hospitals during the forecast period.
Moreover, the rising number of hospital admissions owing to the rising prevalence of chronic diseases and growing geriatric population is boosting the demand for maintaining proper patient related data and its quick access as and when needed. The CC&C provides an improved means of communication, which in turn increases the operational efficiency of the hospitals and clinics.
Get a Free Sample Copy of this Report@ https://www.precedenceresearch.com/sample/1368
Technological advancements introduced in the clinical communication and collaboration systems is expected to drive the demand in the forthcoming years. The installation of new technologies such as Bluetooth connectivity, artificial intelligence (AI), and internet of things (IoT) enables the healthcare staffs to remotely use the CC&C systems from their smartphones. These technologies will also enable to keep a track of the latest and past medical history of the patients that can provide useful information regarding the patient’s treatment in future. Therefore, these latest features may increase the efficiency of the hospital and can contribute towards the betterment of the patient care.
With increased adoption of CC&C systems in hospitals and clinics, the physical interaction between healthcare members and the patients is expected to decrease, while there would be anincreased virtual communication. This may increase the risk of the medical errors due to the lack of proper communication and hence, this is a major challenge to the market players.
Scope of the Clinical Communication and Collaboration Market
North America dominated the global clinical communication and collaboration market in 2020. The developed healthcare infrastructure facilitates the adoption of advanced technologies in order to improve the operational efficiency of the hospitals. The growing number of patients in North America is a major factor that boosts the adoption of CC&C in the hospitals and clinics in the region.According to the CDC, in 2019, there were 45 million outpatient surgeries, over 900 million physician visits, and 155 million emergency department visits in US.
Asia Pacific is estimated to be the most opportunistic market during the forecast period. This is majorly due to the increased investments in the urbanization and healthcare infrastructure development activities. Further, the untapped markets in this region provides promising opportunities to the market players. Moreover, the nations such as Australia, Indonesia, and Singapore have witnessed a rapid traction in the adoption of digital healthcare platforms in the recent years. Telemedicine has played a significant role in the surging popularity of the digital health platforms. Therefore, rising popularity of digital and advanced systems is expected to drive the market growth in this region in the foreseeable future.
Read Also: Medical Implants Market Size to Touch US$ 145.6 Bn by 2030 – Daily Tech Bulletin
Based on component, the solution segment dominated the market in 2020.The integration of advanced alarm system, text messaging, alerts and notification system, and video communication in a single platform. Further, the introduction of IoT is the trending technology introduced that is expected to drive the growth of this segment during the forecast period.
Based on end use, the clinics segment is expected to be the fastest-growing segment, owing to the increased number of physician visits and rising number of private clinics across the developed and developing regions. The increasing demand for the healthcare services is boosting the growth of the clinics.
Based on deployment, the hosted segment is expected to be the fastest-growing segment. This can be attributed to the rapidly surging adoption of the cloud-based storage services across the globe due to its low cost. Further, the cloud-based storage allows quicker access to data and helps in real-time data sharing that might play a critical role in serving the patients efficiently. Hence, this segment is expected to grow rapidly during the forecast period.
In July 2021, Vocera Communications, Inc., introduced Vocera Edge, a cloud-based clinical communication and collaboration software for the smartphones that enables the healthcare system to efficiently access electronic health record and improves communication among the doctors and staffs. The various developmental strategies like new product launches with latest and innovative features fosters market growth and offers lucrative growth opportunities to the market players.
Some of the prominent players in the global clinical communication and collaboration market include:
- Vocera Communications, Inc.
- Jive Sotware
- Microsoft Corporation
- Everbridge
- Ascom
- TigerConnect
- Cisco Systems Inc.
- UDG Healthcare PLC
- Spok Inc.
- NEC Corporation
- Intelligent Business Communication
- Voalte
Segments Covered in the Report
By Component
- Solution
- Service
By End Use
- Hospitals
- Clinics
By Deployment
- Hosted
- On-Premise
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Clinical Communication and Collaboration Market
5.1. COVID-19 Landscape: Clinical Communication and Collaboration Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Clinical Communication and Collaboration Market, By Component
8.1. Clinical Communication and Collaboration Market, by Component Type, 2021-2030
8.1.1. Solution
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Service
8.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Clinical Communication and Collaboration Market, By End Use
9.1. Clinical Communication and Collaboration Market, by End Use, 2021-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Clinics
9.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Clinical Communication and Collaboration Market, By Deployment
10.1. Clinical Communication and Collaboration Market, by Deployment, 2021-2030
10.1.1. Hosted
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. On-Premise
10.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Clinical Communication and Collaboration Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Component (2019-2030)
11.1.2. Market Revenue and Forecast, by End Use (2019-2030)
11.1.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Component (2019-2030)
11.1.4.2. Market Revenue and Forecast, by End Use (2019-2030)
11.1.4.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Component (2019-2030)
11.1.5.2. Market Revenue and Forecast, by End Use (2019-2030)
11.1.5.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Component (2019-2030)
11.2.2. Market Revenue and Forecast, by End Use (2019-2030)
11.2.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Component (2019-2030)
11.2.4.2. Market Revenue and Forecast, by End Use (2019-2030)
11.2.4.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Component (2019-2030)
11.2.5.2. Market Revenue and Forecast, by End Use (2019-2030)
11.2.5.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Component (2019-2030)
11.2.6.2. Market Revenue and Forecast, by End Use (2019-2030)
11.2.6.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Component (2019-2030)
11.2.7.2. Market Revenue and Forecast, by End Use (2019-2030)
11.2.7.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Component (2019-2030)
11.3.2. Market Revenue and Forecast, by End Use (2019-2030)
11.3.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Component (2019-2030)
11.3.4.2. Market Revenue and Forecast, by End Use (2019-2030)
11.3.4.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Component (2019-2030)
11.3.5.2. Market Revenue and Forecast, by End Use (2019-2030)
11.3.5.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Component (2019-2030)
11.3.6.2. Market Revenue and Forecast, by End Use (2019-2030)
11.3.6.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Component (2019-2030)
11.3.7.2. Market Revenue and Forecast, by End Use (2019-2030)
11.3.7.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Component (2019-2030)
11.4.2. Market Revenue and Forecast, by End Use (2019-2030)
11.4.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Component (2019-2030)
11.4.4.2. Market Revenue and Forecast, by End Use (2019-2030)
11.4.4.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Component (2019-2030)
11.4.5.2. Market Revenue and Forecast, by End Use (2019-2030)
11.4.5.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Component (2019-2030)
11.4.6.2. Market Revenue and Forecast, by End Use (2019-2030)
11.4.6.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Component (2019-2030)
11.4.7.2. Market Revenue and Forecast, by End Use (2019-2030)
11.4.7.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Component (2019-2030)
11.5.2. Market Revenue and Forecast, by End Use (2019-2030)
11.5.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Component (2019-2030)
11.5.4.2. Market Revenue and Forecast, by End Use (2019-2030)
11.5.4.3. Market Revenue and Forecast, by Deployment (2019-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Component (2019-2030)
11.5.5.2. Market Revenue and Forecast, by End Use (2019-2030)
11.5.5.3. Market Revenue and Forecast, by Deployment (2019-2030)
Chapter 12. Company Profiles
12.1. Vocera Communications, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Jive Sotware
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Microsoft Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Everbridge
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Ascom
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. TigerConnect
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Cisco Systems Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. UDG Healthcare PLC
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Spok Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. NEC Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Intelligent Business Communication
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. Voalte
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1368
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
